glyoxal has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cikot, M; Isiksacan, N; Kasapoglu, P; Sahingoz Erdal, G; Servi, EY; Ugur, H; Yaman, M | 1 |
| Cheewatanakornkool, K; Dass, CR; Manchun, S; Sriamornsak, P | 1 |
2 other study(ies) available for glyoxal and Colorectal Neoplasms
| Article | Year |
|---|---|
Measurement of Advanced Glycation End Products Could Be Used as an Indicator of Unhealthy Nutrition for Colorectal Cancer Risk.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Glycation End Products, Advanced; Glyoxal; Humans; Magnesium Oxide; Middle Aged; Pyruvaldehyde | 2022 |
Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Colon; Colorectal Neoplasms; Cross-Linking Reagents; Delayed-Action Preparations; Dextrins; Doxorubicin; Drug Liberation; Formaldehyde; Glyoxal; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Mice; Rectum | 2015 |